The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The efficacy and safety of transarterial chemoembolization combined with cadonilimab and lenvatinib for unresectable hepatocellular carcinoma: A phase II clinical trial.
 
Guo Liang
No Relationships to Disclose
 
Shanzhi Gu
No Relationships to Disclose
 
Yabing Guo
No Relationships to Disclose
 
Hailiang Li
No Relationships to Disclose
 
Jingfeng Liu
No Relationships to Disclose
 
Jibing Liu
No Relationships to Disclose
 
Ming Huang
No Relationships to Disclose
 
Yinghua Zou
No Relationships to Disclose
 
Luke Huang
Employment - Akeso Biopharma
 
Yangyang Zhang
Employment - Akeso Biopharma
 
Ting Liu
Employment - Akeso Biopharma
 
Wei Liu
Employment - Akeso Biopharma
 
Zhongmin Wang
Leadership - Zhongmin Wang
 
Baiyong Li
Leadership - Baiyong Li
 
Yu Xia
Leadership - Akeso Biopharma (Inst)